We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.3B
AUM Growth
+$1.38B
Cap. Flow
-$639M
Cap. Flow %
-3.49%
Top 10 Hldgs %
37.51%
Holding
256
New
14
Increased
34
Reduced
47
Closed
63

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$418M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$235M
3
EXEL icon
Exelixis
EXEL
+$219M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$191M
5
SJR
Shaw Communications Inc.
SJR
+$183M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$152M
2
CLVT icon
Clarivate
CLVT
+$127M
3
SGFY
Signify Health, Inc.
SGFY
+$113M
4
LHCG
LHC Group LLC
LHCG
+$111M
5
ATVI
Activision Blizzard
ATVI
+$87M

Sector Composition

Rank Sector Weight
1 Healthcare 33.33%
2 Technology 18.46%
3 Financials 12.48%
4 Industrials 7.09%
5 Communication Services 7.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSTD
126
DELISTED
Northern Star Investment Corp. IV
NSTD
$1.01M 0.01%
100,000
– –
OKLO
127
Oklo
OKLO
$7.83B
$998K 0.01%
98,300
– –
AMRS
128
DELISTED
Amyris Inc.
AMRS
$961K 0.01%
706,700
-293,300
-29% -$419K
SMC
129
Summit Midstream
SMC
$470M
$894K ﹤0.01%
58,214
+15,159
+35% +$257K
LEGN icon
130
Legend Biotech
LEGN
$4.24B
$849K ﹤0.01%
17,600
-729,014
-98% -$35.7M
CLVR
131
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$736K ﹤0.01%
64,265
-24,687
-28% -$304K
MTAL.WS
132
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$602K ﹤0.01%
825,000
– –
LUNRW
133
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$532K ﹤0.01%
950,000
– –
BTTX
134
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$509K ﹤0.01%
699,042
-114,514
-14% -$135K
EDU icon
135
New Oriental
EDU
$8.88B
$502K ﹤0.01%
13,000
– –
GRND.WS
136
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$481K ﹤0.01%
540,000
– –
KRTX
137
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$400K ﹤0.01%
2,200
– –
GATEW
138
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$223K ﹤0.01%
1,485,000
– –
SLDPW icon
139
Solid Power Inc Warrant
SLDPW
$6.93M
$178K ﹤0.01%
405,316
– –
AAC.WS
140
DELISTED
Ares Acquisition Corporation Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AAC.WS
$176K ﹤0.01%
200,000
– –
SEDA.WS
141
DELISTED
SDCL EDGE Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A ordinary share at an exercise price of $11.50
SEDA.WS
$175K ﹤0.01%
866,250
– –
KCGI.WS
142
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$145K ﹤0.01%
581,400
– –
IVCPW
143
DELISTED
Swiftmerge Acquisition Corp. Warrants
IVCPW
$124K ﹤0.01%
990,000
– –
NETC.WS
144
DELISTED
Nabors Energy Transition Corp. Warrants, exercisable for one share of Class A Common Stock
NETC.WS
$92.5K ﹤0.01%
450,000
– –
SCRMW
145
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$78.3K ﹤0.01%
333,330
– –
FRXB.WS
146
DELISTED
Forest Road Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FRXB.WS
$49.6K ﹤0.01%
250,000
– –
CORS.WS
147
DELISTED
Corsair Partnering Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
CORS.WS
$47.9K ﹤0.01%
233,330
– –
DISAW
148
DELISTED
Disruptive Acquisition Corporation I Warrant
DISAW
$42K ﹤0.01%
466,667
– –
UTAAW
149
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$42K ﹤0.01%
175,000
– –
PSPC.WS
150
DELISTED
Post Holdings Partnering Corporation Redeemable Warrants, each whole warrant exercisable for one share of Series A common stock at an exercise price of $11.50
PSPC.WS
$40K ﹤0.01%
266,666
– –
4 5
6
7 8

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2023 Portfolio in Review

As of Q1 2023, Thomas Steyer held 256 positions worth $18.3B, up 8.2% from $16.9B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Thomas Steyer withdrew a net $639M in Q1 2023, closing 63 positions and reducing 47 holdings. Its most notable exit was AbbVie, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 32% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in UnitedHealth worth $409M.

  • Thomas Steyer's largest Q1 2023 buy was UnitedHealth: 866,000 shares worth $409M.
  • Thomas Steyer added most to Alphabet (Google) Class C in Q1 2023, an estimated $235M increase.
  • Thomas Steyer's biggest Q1 2023 reduction was Activision Blizzard, cutting an estimated $87M.
  • Thomas Steyer fully exited AbbVie in Q1 2023, selling an estimated $152M.
  • Thomas Steyer's ten largest holdings make up 38% of its $18.3B portfolio in Q1 2023.
  • Thomas Steyer opened 14 new positions and closed 63 in Q1 2023.
  • Thomas Steyer's portfolio value rose 8.2% quarter-over-quarter to $18.3B.

Based on Farallon Capital Management's 13F filing for Q1 2023, filed 15 May 2023.